Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
65.69
-2.33 (-3.43%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Moderna Inc
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
99
100
Next >
7 Sorry Blue-Chip Stocks to Sell in April Before It’s Too Late
April 04, 2023
These once dominant blue-chip names have fallen out of favor with investors and should be sold before more damage is done.
Via
InvestorPlace
Pfizer Slapped With Additional Patent Infringement Lawsuit Over Its Famed COVID-19 Shots
April 04, 2023
Via
Benzinga
This Foreboding Sign Looms Over Moderna's Chart
April 04, 2023
Via
Benzinga
2 Top Biotech Stocks to Buy in April
April 04, 2023
Right now you can pick up these stocks on the dip.
Via
The Motley Fool
Looking At Moderna's Recent Unusual Options Activity
April 03, 2023
Via
Benzinga
Could This Move by Johnson & Johnson Equal Billions for Moderna?
April 02, 2023
An RSV vaccine could be a driver of blockbuster revenue.
Via
The Motley Fool
Check Out What Whales Are Doing With MRNA
March 28, 2023
Via
Benzinga
Looking At Moderna's Recent Unusual Options Activity
March 27, 2023
Via
Benzinga
3 Things About Moderna That Smart Investors Know
March 25, 2023
Moderna stock has climbed more than 400% over the past three years.
Via
The Motley Fool
COVID Remains A Global Threat – NanoViricides Set To Begin Clinical Trials For Pan-Coronavirus Drug To Help Defeat COVID Once And For All
March 31, 2023
Effective treatments for COVID-19 remain very few and very limited in their capabilities, even after three years. As a result, there are still high rates of hospitalizations and COVID remains many...
Via
Benzinga
11 Stocks: 9 Dividend Payers 2 For Growth
March 30, 2023
Not all stocks are the same, and not all stocks serve the investor’s needs.
Via
Talk Markets
J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out
March 29, 2023
The company says it's refocusing its portfolio to focus on transformational medicines.
Via
Investor's Business Daily
Moderna's CEO Just Gave Investors a Huge Reason to Sell the Stock
March 29, 2023
The stock looks overpriced, and that's without taking into account all the risks.
Via
The Motley Fool
The Ultimate Growth Stock to Buy With $150 Right Now
March 29, 2023
Moderna's shares have climbed nearly 700% over the past five years.
Via
The Motley Fool
(MRNA) - Analyzing Moderna's Short Interest
March 23, 2023
Via
Benzinga
Moderna, Generation Bio Collaborate To Develop Non-Viral Genetic Medicines
March 23, 2023
Via
Benzinga
Check Out What Whales Are Doing With MRNA
March 22, 2023
Via
Benzinga
2 Nasdaq 100 Stocks to Buy Hand Over Fist Right Now
March 28, 2023
Both have plenty of growth in the future, not to mention impressive histories.
Via
The Motley Fool
Could CRISPR Therapeutics Become the Next Moderna?
March 27, 2023
Both companies use cutting-edge technology.
Via
The Motley Fool
Why Generation Bio Shares Are Trading Higher Today
March 23, 2023
Generation Bio (NASDAQ: GBIO) shares are trading higher on Thursday after the company and Moderna (NASDAQ: MRNA) announced a collaboration to develop non-viral genetic medicines.
Via
Benzinga
7 Blue-Chip Stocks Sitting in the Sweet Spot
March 23, 2023
Although blue-chip stocks carry a reputation for being bulky and not exciting, these large enterprises can really move.
Via
InvestorPlace
Apple Jumps Movie Production Bandwagon, Billionaire Jim Ratcliffe Bids For Manchester United, Elon Musk Seeks Funding For SpaceX From Middle-Eastern Fund: Today's Top Stories
March 23, 2023
Bloomberg
Via
Benzinga
China's First mRNA Vaccine: Drugmaker CSPC Wins China's Approval For COVID-19 Vaccine
March 22, 2023
Chinese health authorities approved CSPC Pharmaceuticals Group Ltd's (OTC: CSPCY) messenger RNA (mRNA) COVID-19 vaccine for emergency use authorization.
Via
Benzinga
Additional COVID-19 Booster Shots? Officials Anticipate FDA Authorization Within Few Weeks
March 21, 2023
The U.S. Food and Drug Administration is reportedly moving toward authorizing a second round of omicron-targeted COVID-19 booster shots for the elderly and other people at high risk.
Via
Benzinga
If You Invested $5,000 in Moderna in 2020, This Is How Much You Would Have Today
March 21, 2023
Moderna might become a multiproduct company over the next few years.
Via
The Motley Fool
Covid Vaccine Battle Brewing: Moderna's Stephane Bancel Vs. Bernie Sanders
March 21, 2023
Moderna CEO Stephane Bancel will face a Senate Committee over pricing plans.
Via
Investor's Business Daily
Moderna Wants $130 Per COVID-19 Vaccine Dose, US Health Authorities Warn Of Incurable Deadly Fungal Infection, Elon Musk Wants Interest Rate Cut: Today's Top Stories
March 21, 2023
Reuters Moderna Wants To Charge About $130 Per COVID-19 Vaccine Dose
Via
Benzinga
Where Did COVID-19 Really Originate? Biden Signs Bill To Declassify Origins Information
March 21, 2023
Via
Benzinga
Moderna Wants To Charge About $130 Per COVID-19 Vaccine Dose
March 21, 2023
From now on, Moderna Inc (NASDAQ: MRNA) expects to charge $130 per dose for its COVID-19 vaccine as purchases move from the government to the private sector.
Via
Benzinga
Credit Suisse's $17B Of AT1 Debt Written Down To Zero, Richard Branson's Virgin Orbit Plans Insolvency, Court Freezes Volkswagen's Russian Assets: Today's Top Stories
March 20, 2023
Reuters
Via
Benzinga
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.